Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Miller

Showing results (221-230 of 236) with videos related to

Pageof 24
Sort By:
Genome Medicine|November 14, 2024
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patientsXiuli Zhang, S Peter Goedegebuure, Michael Y Chen, et al.
The International Journal of Cardiovascular Imaging|December 31, 2024
Myocardial ischaemia following COVID-19: a cardiovascular magnetic resonance studyJ Ranjit Arnold, Jian L Yeo, Charley A Budgeon, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Experimental Hematology|May 17, 2016
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaMalachi Griffith, Obi L Griffith, Kilannin Krysiak, et al.
Nature Cancer|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trialElizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.
Arxiv|December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trialsKartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Nature|January 13, 2012
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingLi Ding, Timothy J Ley, David E Larson, et al.
The New England Journal of Medicine|December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S Welch, Allegra A Petti, Christopher A Miller, et al.
JAMA Cardiology|April 15, 2026
Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis: Insights From the EVOLVED Randomized Clinical TrialNeil J Craig, Krithika Loganath, Russell J Everett, et al.
JAMA|October 28, 2024
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical TrialKrithika Loganath, Neil J Craig, Russell J Everett, et al.
Pageof 24

Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
Genome Medicine|November 14, 2024
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patientsXiuli Zhang, S Peter Goedegebuure, Michael Y Chen, et al.
The International Journal of Cardiovascular Imaging|December 31, 2024
Myocardial ischaemia following COVID-19: a cardiovascular magnetic resonance studyJ Ranjit Arnold, Jian L Yeo, Charley A Budgeon, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Experimental Hematology|May 17, 2016
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaMalachi Griffith, Obi L Griffith, Kilannin Krysiak, et al.
Nature Cancer|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trialElizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.
Arxiv|December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trialsKartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Nature|January 13, 2012
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingLi Ding, Timothy J Ley, David E Larson, et al.
The New England Journal of Medicine|December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S Welch, Allegra A Petti, Christopher A Miller, et al.
JAMA Cardiology|April 15, 2026
Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis: Insights From the EVOLVED Randomized Clinical TrialNeil J Craig, Krithika Loganath, Russell J Everett, et al.
JAMA|October 28, 2024
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical TrialKrithika Loganath, Neil J Craig, Russell J Everett, et al.
Pageof 24